An interventional study of Inspiratoty Muscle training and Usual Care in Mild Cognitive Impairment (MCI), sponsored by University of West Attica. Recruiting at 1 site in Greece. Open to participants aged 60 Years to 90 Years. Per ClinicalTrials.gov, last updated 2025-08-28.
Sponsored by University of West Attica · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 29 studies in Cognitive Dysfunction with a site in Greece — 15 open to participants now, 17 under way, 2 of them phase 3. Cognitive Dysfunction · Greece.
Among the 29 studies in Cognitive Dysfunction with a site in Greece, this one is the 18th largest by planned enrollment of the 22 interventional ones that give a count, is one of 12 that started in 2025, is one of 17 with no phase, reaches primary completion later than 9 of the 16 other live ones, and was the 21st registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →15 of the 29 studies in Cognitive Dysfunction with a site in Greece are open now. Recruiting first, the newest first:
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Sites in Greece, Australia, Austria and 14 more countries
Ages 18+
Aristotle University Of Thessaloniki · Sites in Greece
University of Patras · Sites in Greece
Ages 50+
University of Thessaly · Sites in Greece, Denmark
Ages 18–65 · Healthy volunteers
Bristol-Myers Squibb · Sites in Greece, United States, Argentina and 14 more countries
Ages 60–85
A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 60 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
29 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 76 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 150 across the 22 interventional studies, 389 across the 7 observational. Of the 6 that completed or were terminated, 1 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 29 have an industry lead sponsor. The 10 most frequent:
University of West Attica is the lead sponsor of 31 studies on the registry; 13 are open to participants now.
University of West Attica has 1 study filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
4 of the studies in Cognitive Dysfunction with a site in Greece that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07672938Panhellenic Federation of Alzheimer's Disease and Related DisordersEffects of Hydroxytyrosol-Rich Olive Polyphenol Dietary Supplement Combined With Mediterranean Diet Adherence on the Cognitive Health of Patients With Mild Cognitive Impairment | 2026-12 |
| NCT07510061University of ThessalyTitle: ICARUS - Psycho-physiological Profiling of Low and High Heat-resilient Individuals | 2027-04-30 |
| NCT07844850Aristotle University Of ThessalonikiBiomarkers as Prognostic Factors of Silent, Cerebral Infarctions in Patients Undergoing High-thromboembolic-risk Transcatheter Interventions | 2027-05-01 |
| NCT07289061Aristotle University Of ThessalonikiPositive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 29 studies in Cognitive Dysfunction with a site in Greece, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to examine the effect of a respiratory muscle strengthening program on the cognitive and physical functioning of patients with neurocognitive disorders (Mild Cognitive Impairment) or those predisposed to them.
The main questions that aims to answer are:
Participants will be:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
IMT that consists of 5set/6 breaths at 50-60% of Maximal Inspiratory Pressure, 5 session per weak for 3 months. Physical and Cognitive training
Other: Inspiratoty Muscle training
Physical and cognitive training
Other: Usual Care
Participants will follow an IMT program through a threshold IMT device which consists of 5 set/6 breaths at 50-60% MIP for 3 months along with their usual physical and cogntive training
Physical and cognitive training
Mini Mental State Examination
Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)
Frontal Assessment Battery
Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)
Addenbrooke's Cognitive Examination
Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)
Time up and Go (TUG)
Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)
Sit-to-Stand test
Time frame: T0 at the beginning, T1 at 3 months (end of intervention), T2 at 6 months (follow-up)
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for Dec 2027, 33 months after the start.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 33 months is above that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of West Attica